Recent findings suggest that post-COVID chronic cough may be driven by neurologic factors, not just respiratory issues.

Similarly, high-certainty evidence revealed a 6.2-mm decrease (95% CI -4.1 to -8.4) in cough severity on the 100-mm visual analog scale (VAS). Findings were published simultaneously in JAMA ...

Participants also completed the Cough Quality of Life Questionnaire (CQLQ) to measure the impact of cough on daily life, and a cough severity visual analogue (VAS) scale to measure cough severity.

A reduction of 23.6 mm from baseline in the cough visual analogue scale (VAS) (p = 0.0005, 95% CI -35.22, -11.94). The cough VAS is a patient-reported subjective assessment of cough severity ...

Response to treatment was quantified pretreatment and 8 weeks after treatment by using a visual analog scale.

The clinic assessed symptoms with a cough-severity visual analogue scale and the Leicester Cough Questionnaire.

Osteoarthritis is common in the UK, with nearly nine million adults over the age of 45 seeking treatment due to painful flare-ups in the knees, hands, hips and spine. Patients whose hands are affected ...

For secondary outcomes, nebulizer and lidocaine throat spray cough treatments reduced the urge-to-cough and cough severity visual analog scale scores compared with placebo (P < .05).

The cough severity was assessed on the visual analog scale, and a value of 30 mm or more was used as the cut-off for inclusion in the study since previous studies have reported that patients with ...

MANCHESTER, England & MOUNTAIN VIEW, Calif., August 27, 2024--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, announced that the first ...